EDTA-K2 Improves the Detection Sensitivity of SARS-CoV-2 IgM and IgG A | IJN
Frontiers | Detection of Impaired IgG Antibody Formation Facilitates the Decision on Early Immunoglobulin Replacement in Hypogammaglobulinemic Patients
Frontiers | Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
Comparison of IgG and neutralizing antibody responses after one or two doses of COVID-19 mRNA vaccine in previously infected and uninfected individuals. - eClinicalMedicine
Immunoglobulin levels by age groups | Download Table
Frontiers | Evaluation of Patient IgM and IgG Reactivity Against Multiple Antigens for Improvement of Serodiagnostic Testing for Early Lyme Disease
Frontiers | Determinants of Serum Immunoglobulin Levels: A Systematic Review and Meta-Analysis
Clinical Value of SARS-CoV2 IgM and IgG Antibodies in Diagnosis of COV | JIR
Serum IgA, IgM, and IgG responses in COVID-19 | Cellular & Molecular Immunology
Comparison of SARS-CoV-2 anti-spike receptor binding domain IgG antibody responses after CoronaVac, BNT162b2, ChAdOx1 COVID-19 vaccines, and a single booster dose: a prospective, longitudinal population-based study - The Lancet Microbe
Antibody responses to SARS-CoV-2 in patients with COVID-19 | Nature Medicine
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients | Science Immunology
Dynamic changes and prevalence of SARS-CoV-2 IgG/IgM antibodies: Analysis of multiple factors - International Journal of Infectious Diseases
Immunoassay for quantification of antigen-specific IgG fucosylation - eBioMedicine
Normal Serum Levels of IgG, IgA, IgM, IgD, and IgE in Saudi Arabia | Annals of Saudi Medicine
Immunoglobulin test results: When to take action and when to provide reassurance | New Zealand Doctor
Detection of IgM and IgG antibodies in patients with coronavirus disease 2019 - Hou - 2020 - Clinical & Translational Immunology - Wiley Online Library
Age-related serum IgG level (mg/dl) with 95% CI levels in healthy children. | Download Scientific Diagram
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodies | Scientific Reports
Rapid Decay of Anti–SARS-CoV-2 Antibodies in Persons with Mild Covid-19 | NEJM
Time course of the sensitivity and specificity of anti-SARS-CoV-2 IgM and IgG antibodies for symptomatic COVID-19 in Japan | Scientific Reports
Neutralising SARS-CoV-2 RBD-specific antibodies persist for at least six months independently of symptoms in adults | Communications Medicine
Detection of persistent SARS-CoV-2 IgG antibodies in oral mucosal fluid and upper respiratory tract specimens following COVID-19 mRNA vaccination | Scientific Reports
Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19 | Nature Communications
Frontiers | Serum IgG Is Associated With Risk of Melanoma in the Swedish AMORIS Study
